Does the sequence of taxane administration affect the outcome of patients with breast cancer in the adjuvant and neoadjuvant settings?

被引：0
|
作者：
Alkan, Ali [2 ]
Sahin, Ugur [2 ]
Altundag, Kadri [1 ]
机构：
[1] Hacettepe Univ, Dept Med Oncol, Inst Oncol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Sch Med, Dept Internal Med, TR-06100 Ankara, Turkey
来源：
MEDICAL ONCOLOGY | 2010年 / 27卷 / 04期
关键词：
Paclitaxel; Docetaxel; Gemcitabin; Taxane; Anthracycline;
D O I：
10.1007/s12032-009-9322-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1430 / 1430
页数：1
相关论文
共 50 条
  • [31] Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
    Tian, Hao
    Ma, Dandan
    Tan, Xuanni
    Yan, Wenting
    Wu, Xiujuan
    He, Cheng
    Zhong, Ling
    Zhang, Yan
    Yu, Bingjie
    Zhang, Yi
    Qi, Xiaowei
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [32] Adjuvant Chemotherapy Following Neoadjuvant Chemoradiation and Surgery for Esophageal Cancer: Does It Improve Outcome?
    Gabriel, E.
    Kim, J.
    Al-Sukhni, E.
    Brady, M.
    Shah, R.
    Attwood, K.
    Hochwald, S.
    Kukar, M.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S177 - S177
  • [33] Concomitant radiation therapy does not affect adjuvant CMF delivery in patients with operable breast cancer.
    Montemurro, F
    Gatti, M
    Faggiuolo, R
    Durando, A
    Choa, G
    Piccinno, R
    Redana, S
    Sismondi, P
    Gabriele, P
    Aglietta, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 75S - 75S
  • [34] Does Neoadjuvant Chemotherapy for Breast Cancer Affect Lymph Node Harvest Rates?
    White, Richard L., Jr.
    Palmer, Pooja P.
    Trufan, Sally J.
    Sarma, Deba
    AMERICAN SURGEON, 2019, 85 (07) : 690 - 694
  • [35] Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?
    Pomponio, Maria K.
    Keele, Luke J.
    Fox, Kevin R.
    Clark, Amy S.
    Matro, Jennifer M.
    Shulman, Lawrence N.
    Tchou, Julia C.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 177 (01) : 137 - 143
  • [36] Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?
    Maria K. Pomponio
    Luke J. Keele
    Kevin R. Fox
    Amy S. Clark
    Jennifer M. Matro
    Lawrence N. Shulman
    Julia C. Tchou
    Breast Cancer Research and Treatment, 2019, 177 : 137 - 143
  • [37] Does the timing of adjuvant chemotherapy after breast cancer surgery affect survival?
    Shannon, CM
    Ashley, S
    Smith, IE
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S160 - S160
  • [38] Outcome after neoadjuvant chemotherapy in Asian breast cancer patients
    Lim, Li Yan
    Miao, Hui
    Lim, Joline S. J.
    Lee, Soo Chin
    Bhoo-Pathy, Nirmala
    Yip, Cheng Har
    Taib, Nur Aishah B. M.
    Chan, Patrick
    Tan, Ern Yu
    Lim, Swee Ho
    Lim, Geok Hoon
    Woo, Evan
    Tan, Yia Swam
    Lee, Jung Ah
    Wong, Mabel
    Tan, Puay Hoon
    Ong, Kong Wee
    Wong, Fuh Yong
    Yap, Yoon Sim
    Hartman, Mikael
    CANCER MEDICINE, 2017, 6 (01): : 173 - 185
  • [39] Advances in the adjuvant and neoadjuvant treatment of breast cancer
    Briest, Susanne
    Stearns, Vered
    WOMENS HEALTH, 2007, 3 (03) : 325 - 339
  • [40] Biomarkers of neoadjuvant/adjuvant chemotherapy for breast cancer
    Iwamoto, Takayuki
    Kajiwara, Yukiko
    Zhu, Yidan
    Iha, Shigemichi
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03) : 27
12345